Scientific article
Case report
Biological and clinical response to Omalizumab in a patient with Bullous Pemphigoid
Published inActa Dermato-Venereologica, vol. 98, no. 2, p. 284-286
Publication date2018
Keywords
- Aged
- Autoantibodies/blood
- Autoantigens/immunology
- Biomarkers/blood
- Biopsy
- Dystonin/immunology
- Female
- Fluorescent Antibody Technique
- Humans
- Immunoglobulin E/blood
- Immunologic Factors/therapeutic use
- Non-Fibrillar Collagens/immunology
- Omalizumab/therapeutic use
- Pemphigoid
- Bullous/blood/diagnosis/drug therapy/immunology
- Remission Induction
- Severity of Illness Index
- Skin/drug effects/immunology/pathology
- Treatment Outcome
Affiliation entities
Research groups
Citation (ISO format)
MENZINGER, Sébastien et al. Biological and clinical response to Omalizumab in a patient with Bullous Pemphigoid. In: Acta Dermato-Venereologica, 2018, vol. 98, n° 2, p. 284–286. doi: 10.2340/00015555-2845
Main files (1)
Article (Published version)
Identifiers
- PID : unige:125831
- DOI : 10.2340/00015555-2845
- PMID : 29136264
Journal ISSN0001-5555
